Different Mutant Runx1 Oncoproteins Program

Different mutant RUNX1 Oncoproteins Program

The molecular impact of RUNX1 mutations in AML

VJHemOnc – Video Journal of Hematology & HemOnc

Are germline RUNX1 mutations different to somatic RUNX1 mutations?

The impact of various chromosomal abnormalities observed in AML & insights into RUNX1-ETO

VJHemOnc – Video Journal of Hematology & HemOnc

Are there germline RUNX1 mutations which predispose to AML?

Using transcriptional network analysis to better understand AML development and evolution

VJHemOnc – Video Journal of Hematology & HemOnc

RRP: One Goal Prevent Cancer

RUNX1 Research Program

Genetic Basis of MDS

Clinical and prognostic implications of WT1 mutations in de novo and R/R AML

VJHemOnc – Video Journal of Hematology & HemOnc

Germ line predisposition to leukaemia

Predicting somatic mutations with OncMTR

Oncotarget: Addiction to Runx1 is partially attenuated by loss of p53

The relationship between chromosome 1 abnormalities and poor prognosis in multiple myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Oncomine Tumor Mutation Load Assay compared to FoundationOne test

Thermo Fisher Scientific

Impact of Chromosome 1 Abnormalities Among Pts with NDMM: Subgroup Analysis from the ENDURANCE Trial

International Myeloma Foundation

Integration of Transcriptome and Cistrome Analyses Identifies the RUNX1 Target Genes Involved

American Pancreatic Association

Dr. Rao on Testing for Somatic and Germline Mutations

Characterizing cellular hierarchies in malignant hematopoiesis using single-cell proteomics

Using And Extending Biomedical Ontologies With Ontoproc

Genomic differences in SMM progressors versus non-progressors

VJHemOnc – Video Journal of Hematology & HemOnc